Structure Therapeutics, Inc. (GPCR)

46.33 -0.50 (-1.07%) USD  |  NASDAQ  |  Apr 22, 11:19
More

Structure Therapeutics Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for GPCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Viking Therapeutics, Inc. Upgrade
Novo Nordisk A/S Upgrade
Revolution Medicines, Inc. Upgrade
Kymera Therapeutics, Inc. Upgrade